Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes

Patrizia Natale,Suetonia C. Palmer,David J. Tunnicliffe,Tadashi Toyama,Giovanni F.M. Strippoli

The Cochrane library（2023）

引用 0|浏览6

暂无评分

摘要

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: This review aims to assess the benefits and harms of GLP‐1 receptor agonists to treat diabetes in people with CKD.

查看译文

关键词

receptor agonists,chronic kidney disease,diabetes,peptide,glucagon-like

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要